Profil
Karl Alexius Tiger Karlsson is the founder of Bluefish Pharmaceuticals AB, founded in 2005, where the title held was President, Chief Executive Officer & Director from 2005 to 2020.
Mr. Karlsson is the founder of Newbury Pharmaceuticals AB, founded in 2020, holding the title Chief Executive Officer starting in 2025.
Current jobs include Director at Alsakali Equity AB and Independent Director at Lotus Pharmaceutical Co., Ltd. starting in 2023.
Former job includes Chief Executive Officer at Rda Interactive LLC in 2002.
Education includes an MBA from Harvard University.
Postes actifs de Karl Karlsson
| Sociétés | Poste | Début |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Directeur Général | 11/11/2025 |
| LOTUS PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 15/06/2023 |
Alsakali Equity AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Karl Karlsson
| Sociétés | Poste | Fin |
|---|---|---|
Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops and sells generic pharmaceuticals | Fondateur | 01/03/2020 |
Rda Interactive LLC | President | 01/01/2002 |
Formation de Karl Karlsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops and sells generic pharmaceuticals | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, research and sells pharmaceutical products | Health Technology |
Rda Interactive LLC | |
Newbury Pharmaceuticals AB
Newbury Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a hybrid pharmaceutical company | Health Technology |
Alsakali Equity AB |
















